Health and Medicine

The 2024 Clinical Hematology and Oncology Conference is designed for hematologists, oncologists, surgeons, radiation oncologists, internists, and others desiring an update in these specialty areas. The primary objective of this course is to bring together clinicians and leading experts in diverse areas of hematology and oncology, affording them an intimate environment in which to discuss new clinical developments and significant advances. Time: 11:00 AM - 5:45 PM Prices: Physicians (MD, DO, MBBS): USD 600.00, RN, NP, PA, Others: USD 375.00, Students, Residents, Fellows: USD 150.00

Critical Issues America 2024 Annual Conference - February 2-3, 2024 The meeting will help participants to identify and manage complications associated with endovascular and open repair of complex aortic disease including: arch descending thoracic, TAAA, pararenal and juxtarenal aneurysms, aortoiliac aneurysms and other miscellaneous pathologies affecting the aorta. CIA will recognize potential treatment failure and the role of advance imaging techniques in the evaluation, treatment, and management of aortic disease. The target audience includes physicians who specialize in vascular surgery, cardiology, interventional radiology, vascular medicine, cardiothoracic surgery, as well as fellows, and allied health professionals. Objectives: Provide an overview of…

Zertifizierte Fortbildung für ÄrztInnen der Neurologie vor Ort in Köln & via Livestream, 02.-03.02.2024. Updates & die neuesten Leitlinien. 16 CME-Punkte wurden bei der zuständigen Ärztekammer angefragt. Jetzt informieren & buchen!

Through a 3-day scientific program, WCF-2024 aims to provide a grand platform for the professionals, decision-makers, and students from the area of chemistry to share their research achievements and more in interactive discussions and technical programs at the event. There will be also a space for companies and institutions to present their technology, service, products, and innovations.

Zertifizierte Fortbildung für ÄrztInnen der Kardiologie vor Ort in Köln & via Livestream, 01.-03.02.2024. Updates & die neuesten Leitlinien. 24 CME-Punkte wurden bei der zuständigen Ärztekammer angefragt. Jetzt informieren & buchen!

31st European Nutrition and Dietetics Conference held at February 01-02, 2024 Dubai, UAE. The conference is focused on theme "Exploring & Enlightening the Significance of Nutrition & Dietetics Health" which covers a broad array of vitally key sessions. Nutrition will lay a platform for scientists, world-class professors, and Nutritionists to discuss an approach for Dietetics Health.”

Transform Customer Engagement Through Innovative, Collaborative & Commercially-Driven Digital Strategies That Harness The Power Of AI & New Tech – Drive Engagement Skywards Through Optimised Omnichannel Strategies – Deliver Data-Driven & Insight-Led Campaigns To HCPs – Powerful, Measurable & Repeatable Success Stories Showcasing The Value Of Digital Engagement

Emerging advances in biopharma development and manufacturing processes are rapidly changing the game for animal health drug development. As this community capitalizes on advanced platform technologies, RNA vaccines and other innovations, this year alone has seen the first-ever vaccine for honeybees – medicines for animal health are on the cusp of something truly exciting. With increased investment, collaboration, and more promising innovation than ever before, the Animal Health Vaccine Development Summit has been curated as the industry's first R AND D-centred forum dedicated solely to showcasing the latest advances in high-value vaccine technologies being harnessed for intervention against infectious disease,…

The 2nd Annual Next Generation Ophthalmic Drug Delivery Summit is returning to San Francisco this January to unite 90+ device engineers, biochemists, preclinical and clinical experts as they discuss how they are optimizing longer-lasting and less invasive delivery to the back of the eye to reduce patient concerns and burden on healthcare systems caused by frequent drug administration. Join 23+ expert speakers from the likes of AbbVie, Boehringer Ingelheim, Bayer, Genentech, Janssen, Novartis, and Clearside Biomedical at the only industry-dedicated event focusing on overcoming key translational challenges of developing and implementing novel delivery technology as they progress their ophthalmic pipelines…

Following Merck announcing their goal to phase out animal use in their work, Astellas and MIMETAS expanding their partnership in immunotherapeutic development, and the domino effects across the field caused by the FDA Modernization Act 2.0, 2023 has set an exciting precedent for the upcoming year. However, the translation rates of oncology therapeutics into the clinic remain at 20%, proving there remains a large unmet need for tools to support drug development efforts in a patient-specific context at the preclinical and early translational levels. At the 8th Annual Tumor Models San Francisco Summit, you will gain practical insights into the…

Although no drug on the market has yet been discovered using AI, we're due to witness an instantaneous transformation soon as AI approaches an inflection point in drug discovery thanks to the increase in collaboration between AI tech development and big pharma. This is evidenced by third-party investment in AI-enabled drug discovery more than doubling annually for the last five years. With ongoing headlines spotlighting GSK, AZ, Novartis, Roche, Bayer, and Sanofi's positive results from their AI-powered drug discovery efforts, industry is teetering on the precipice of a breakthrough and the time to get involved is now! Uniting computational and…

With new clinical data and more ground-breaking advancements in the technology underpinning microbiome research, Europe's leading microbiome organisations are paving the way for drug development! Join us at the 8th Microbiome Movement- Drug Development Summit Europe where we will cover the most exciting progress in the microbiome world, from expanded analytics and larger-scale manufacturing to the most pressing challenges from translation to regulations. In January, 150+ microbiome innovators will be united in Barcelona for the flagship meeting for European microbiome-based therapeutic developers. We are bringing together microbiome trailblazers across industry, academia and investors to share their insights across autoimmune disorders,…

DDR inhibitor development is evolving rapidly, marked by the continuous emergence of new targets. AstraZeneca and Merck reaffirm their commitment to DDR inhibitors, yet more pharmaceutical companies like Roche and Gilead are diving into this therapeutic strategy; biotech companies like Artios and IDEAYA remain dedicated to delivering safe and effective treatments to patients. The unmet need for cancer therapies reinforces the critical importance for the community to unite at the 7th Annual DDR Inhibitors Summit in Boston, January 2024, to advance first-in-class oncology treatments for patients. This year's conference has undergone a renovation to maximize your experience, featuring a new…

The diagnosis, management, and prevention of common rhythm disorders, atrial fibrillation, and ventricular arrhythmias will be reviewed along with challenging aspects of congestive heart failure, coronary artery disease, valvular heart disease, and myocardial disease. There will be an emphasis on patient management, case-based presentations, and panel discussion sessions to provide interaction between the faculty and attendees. Mayo Clinic and guest faculty will share "pearls" to aid in the evaluation and assessment of patients with commonly seen cardiovascular diseases. Special sessions will highlight ECG pearls useful in all aspects of cardiology. Price: Registration: USD 990.00 Speakers: fred kusumoto, Paul Friedman, Michael…

Advance Scalability, Accessibility and Affordability of Autologous Cell Therapies As the cell therapy space bears witness to an increasing number of autologous therapies gaining regulatory approval, the essential role of the manufacturing ecosystem has never been clearer. It is business critical for cell therapy drug developers to have a robust strategy for scale up whilst overcoming the labour and cost intensive nature of batch manufacturing to reduce the cost of goods. Enter the timely arrival of the inaugural Decentralized Manufacturing for Cell Therapy Summit, the pioneering forum for cell therapy leaders across manufacturing to gain practical insights into the strategic…

As device developers of all sizes grapples with the updated transition timeline for EU MDR compliance and the recent EU AI Act approval falls short of expectations, the question looms: how can regulatory compliance align seamlessly with the pace of innovation? Dedicated to shedding light on the intricate layers of European regulation, integrated cybersecurity features and forecasted uncertainties around AI, the 2nd Medical Device Software Development Summit Europe serves as a pivotal platform to better align software innovation with compliance. Join over 80 experts in Software Engineering, Regulatory Affairs, R and D Operations, Product Management and more to harmonise cross-functional…

A year on from the first European allogenic approval, join 60+ industry experts as they discuss the current landscape and promising emerging pipelines at the 3rd Allogeneic Cell Therapies Summit Europe! Hear expert insights from Caribou Biosciences, Cellectis, AdaptImmune and many more as they share their recent breakthroughs and strategies to overcome challenges such as alloreactivity, durability, and upscaling their therapies. As Europe's only conference purely focused on allogeneic research, this is the only opportunity for you to network with other industry leaders, solve shared challenges and have your burning questions answered by leading experts. URL: Tickets: https://go.evvnt.com/2020219-2?pid=154 Time: 9:00…

As the incidence of melanoma continues to rise rapidly in the United States and around the world, the need to educate clinicians from various specialties on the disease also increases. During this course nationally recognized experts will present information on prevention, risk assessment, early detection, genetic factors, and current and future treatment choices for melanoma patients. Issues concerning surgical management, adjuvant therapy, advanced disease therapy, and personalizing the course of treatment for individual patients will also be discussed. This course is designed to provide information that will help clinicians in their decision making regarding these difficult patient problems. The course…

The 15th Annual Symposium on Neurovascular Disease will provide attendees with updates on emerging technologies, including artificial intelligence in neurovascular and stroke imaging, new frontiers in stroke therapy, and updates on major neurovascular trials as a means of expediting the care of patients with stroke and other neurovascular diseases. A special session dedicated to cerebral aneurysms and AVMs will be offered, which will provide updates on AVM surgery after ARUBA, and radiosurgery for cerebral and spinal AVMs. The session with end with a discussion on different cerebral aneurysm cases. After lunch, a session on the management of stroke patients will…

Topics include pain management, latest hypertension guidelines, diabetes mellitus management, cholesterol management, immunizations, etc. All topics germane to primary care! Family practice, internal medicine, general practice, OB/GYN, subspecialists, nurse practitioners, and physician assistants are welcome. Speakers: Tommy Cross, MD Category: Conferences | Science, Health and Medicine | Family Medicine Date and Time: 26th January 2024 at 8:00 am to 29th January 2024 at 10:00 am